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Abstract
35S-Radiolabeled cultured Sertoli cells from immature rat testis were extracted with detergent and the different
proteoheparan sulfate (HSPG) forms of the extract were discriminated and quantified on the basis of their high anionic
charge, hydrodynamic size, lipophilic properties, susceptibility to trypsin and phosphatidylinositol phospholipase C (PI-
PLC). Trypsin released 50% of total cellular HSPG corresponding to 80% of total hydrophobic HSPG. Trypsin-accessible
HSPG were presumed to be integral membrane species. Trypsin-resistant HSPG, probably intracellular, distributed into non-
lipophilic (37.5%) and lipophilic (12.5%) populations. Biochemical analysis of PG copurified with plasma membrane
confirmed the existence of hydrophobic HSPG integrated into this structure. Among hydrophobic HSPG accessible to
trypsin, 35% were PI-PLC released and radiolabeled by [3H]inositol indicating that about one third of integral membrane
HSPG were intercalated into the plasma membrane through a phosphatidylinositol anchor (glypican type). PI-PLC-resistant
forms represented HSPG inserted into the membrane through a hydrophobic segment of the core protein (syndecan type).
No lipophilic PG was present in other cell compartments (culture medium, cell periphery, extracellular matrix). 125I-
Iodinated hydrophobic HSPG were deglycanated and submitted to SDS-polyacrylamide gel electrophoresis. In the glypican
family, a core protein (64^65 kDa) was detected, whereas in the syndecan family, bands of 60 and 68 kDa were observed
which may correspond to self-association of different core proteins. In Sertoli cell, specific functional attributes of different
integral membrane HSPG forms remain to be investigated. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Heparan sulfate proteoglycans (HSPG) are com-
posed of a core protein to which negatively charged
and ¢ne structure heparan sulfate (HS) chains are
covalently attached [1,2]. In animal tissues, HSPG
are mostly located in two major areas: in the extra-
cellular matrix, and particularly in the basement
membrane where they take part in the development
of supramolecular architecture, and at the cell sur-
face. Basement membrane is a specialized sheet-like
extracellular matrix, biochemically complex. Its het-
erogeneous structure consists in laminin, collagen
type IV, nidogen and HSPG such as perlecan, agrin
[3] and, recently identi¢ed, collagen type XVIII [4].
Cell surface HSPG are associated to the plasma
membrane according to three modes. The ¢rst con-
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sists in a direct intercalation of the core protein into
the lipid bilayer, through a transmembrane hydro-
phobic sequence (transmembrane HSPG). The sec-
ond is realized by a linkage to the external lea£et
of the membrane through a glycosylphosphatidylino-
sitol (GPI) moiety covalently bound to the core pro-
tein (GPI-HSPG). Transmembrane HSPG, which
notably include syndecan-1, -2, -3, -4 [5], betaglycan
(type III transforming growth factor L (TGFL) re-
ceptors) [6,7] and splice variants of CD44 (hyalur-
onan receptors) [8,9], and GPI-HSPG, which are
mostly represented by the glypican family (glypi-
can-1 to -6) [10,11], are both designated as integral
membrane HSPG. Syndecans and glypicans are indi-
vidually expressed in distinct cell-, tissue- and devel-
opment-speci¢c patterns [5,10]. The third mode of
cell surface association concerns the peripheral
HSPG which achieved interactions of their HS
chains with sites referred to membrane receptors
[12]. Relatively high concentrations of free heparin
or salt solutions displace these peripheral HSPG
from their receptors but do not release integral mem-
brane HSPG which are e⁄ciently extracted with de-
tergent [13].
Cell surface-associated HSPG play highly diversi-
¢ed roles relative to their localization, to the ability
of HS chains, and less extensively, of core proteins
[14] to interact with numerous molecules. An increas-
ing variety of HS ligands have been described, in-
cluding extracellular matrix proteins, cell-cell adhe-
sion molecules, proteolytic and lipolytic enzymes,
lipoproteins, protease inhibitors, growth factors, cy-
tokines, chemokines, microorganisms such as viruses,
bacteria and protozoa [5]. Thus, cell surface HSPG
may participate in cell adhesion, proliferation and
motility, bioavailability regulation and activity of
soluble polypeptide factors, modulation of lipid me-
tabolism, attachment of pathogenic agents and inva-
sion of host cells.
In seminiferous tubules of testis, epithelial type
Sertoli cells provide structural support for the devel-
opment of germinal cells and are in contact by their
basal surface with a basement membrane [15]. Base-
ment membrane is cooperatively produced by Sertoli
and peritubular cells which surround the seminifer-
ous tubules [16], these two cell types synthesizing
HSPG [17,18]. In addition to the synthesis of extra-
cellular HSPG, Sertoli cells elaborated HSPG with
hydrophobic features suggesting an integral mem-
brane disposition [19].
Sertoli cells are the target of many growth factors,
for example, basic ¢broblast growth factor (bFGF)
and TGFL which regulates estradiol production [20].
Although not evidenced in Sertoli cells, it is very
likely that, as in other cells, integral membrane
HSPG take part in the activation of bFGF [21,22]
and TGFL [23] signaling receptors.
Moreover, we have shown that synthesis inhibition
[24] and sulfation degree lowering [25] of Sertoli cell
proteoglycans are accompanied by an increase in fol-
licle stimulating hormone (FSH)-stimulated estradiol
synthesis. Modi¢cations of estradiol production re-
sulted from a decrease in cyclic adenosine mono-
phosphate (cAMP) phosphodiesterase activity and a
steroidogenesis stimulation in a post-cAMP step
[24,25]. These data indicated that proteoglycans
(PG) functionally interfere with FSH signal transduc-
tion.
Thus, due to their strategic position between extra-
cellular and intracellular compartments, integral
membrane HSPG may constitute good candidates
for this regulation, but they are not yet characterized
in Sertoli cells. As a ¢rst biochemical approach, the
present work aims at clarifying the cell distribution
of Sertoli cell HSPG and studying their attachment
mode to the plasma membrane. Biochemical analysis
indicated the existence of both transmembrane
HSPG and GPI-HSPG.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s minimal essential me-
dium (DMEM), Ham’s F-12 medium, sulfate-free
and sulfate/inositol-free DMEM/Ham’s F-12 me-
dium were from J. Boy (Reims, France). Bovine
pancreas deoxyribonuclease (DNase type I), hyal-
uronidase (type I-S), Triton X-100, n-octyl-D-gluco-
pyranoside, L-phosphatidylcholine (type V-E), pro-
tease inhibitors, test kits for 5P-nucleotidase and for
acid phosphatase were purchased from Sigma (Saint
Quentin Fallavier, France). Phosphatidylinositol
phospholipase C (PI-PLC from Bacillus cereus) and
collagenase-dispase were obtained from Boehringer
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Mannheim (Meylan, France). Trypsin was from
Gibco-BRL (Cergy Pontoise, France). Ultroser SF
(steroid-free serum substitute) and DEAE-Trisacryl
were provided by IBF-Biotechnics (Villeneuve la
Garenne, France). Sepharose CL-2B, Sepharose
CL-4B, octyl-Sepharose CL-4 B and FPLC Mono
Q column were from Pharmacia (Saint Quentin-Yve-
lines, France). Heparitinase (EC 4.2.2.8; heparitin
sulfate lyase) was from Miles Laboratories (Coger,
Paris, France). [35S]Sulfate (39^59 Tbq/mg) and
[125I]Na (629 GBq/mg) were from Amersham (Les
Ulis, France). myo-[2-3H(N)]Inositol (2.96^4.44
TBq/mmol) was obtained from NEN (Les Ulis,
France). Cationic nylon (Zeta-Probe) was purchased
from Bio-Rad (Ivry sur Seine, France). All other
reagents were of analytical biology grade.
2.2. Preparation of Sertoli cell cultures
Twenty-day-old Sprague-Dawley rats from our
own colony were killed by cervical dislocation. Tes-
ticular Sertoli cells were obtained by sequential enzy-
matic digestion including trypsin, collagenase, hyal-
uronidase and deoxyribonuclease, as previously
described [26,27]. Cells were plated at a concentra-
tion of 2.5U105 cells/cm2 in 75 cm2 plastic £asks and
cultured for 24 h in Ham’s F-12-DMEM containing
2% Ultroser SF, in a humidi¢ed atmosphere of 95%
air/5% CO2, at 32‡C. After 48 h, culture medium was
discarded and replaced by free-Ultroser SF Ham’s F-
12-DMEM medium. On day 3 of culture, residual
germinal cells were removed by brief hypotonic treat-
ment using 20 mM Tris-HCl (pH 7.4) [27]. Sertoli
cells were used on day 5 after plating.
2.3. Radiolabeling
Con£uent Sertoli cells were metabolically radiola-
beled for 48 h in sulfate-free Ham’s F-12-DMEM
containing 5 WCi/ml of carrier-free sulfate [35S]sulfate
or, in some experiments, by [35S]sulfate (5 WCi/ml)
and [3H]inositol (5 WCi/ml) in sulfate- and inositol-
free medium.
2.4. Isolation of plasma membrane
A plasma membrane-enriched fraction of Sertoli
cells was isolated as essentially described by Lories
et al. [28]. Cell cultures, labeled by [35S]sulfate, were
washed and scraped in 1 mM NaHCO3 with a rub-
ber policeman, at 4‡C. The cell suspension, adjusted
to 1 mM EDTA, was homogenized with a Potter-
Elvehjem homogenizer and centrifugated (1000Ug,
10 min). After centrifugation of the preceding super-
natant (25 000Ug, 30 min), crude membrane prepa-
ration was recuperated. This fraction was resus-
pended in 10% (w/w) sucrose solution in PBS,
layered on top of a 32% (w/w) sucrose solution in
PBS and centrifugated (100 000Ug, 2 h). The major-
ity of the plasma membrane, recovered at the inter-
face of the sucrose solutions, was washed with PBS,
heparin solution (100 mg/ml in PBS), and solubilized
in 4 M guanidine chloride in 10 mM Tris-HCl bu¡er,
pH 7.2, in the presence of protease inhibitors (0.2
mM phenylmethylsulfonyl £uoride, 10 mM N-ethyl-
maleimide, 100 mM 6-aminohexanoic acid, 1 g/ml
pepstatin, 20 mM EDTA and 5 mM benzamidine-
HCl).
Activities of enzymatic subcellular markers (5P-nu-
cleotidase and acid phosphatase for plasma mem-
brane and lysosomes respectively) were assessed, ac-
cording to the manufacturer’s instructions, in
supernatant of crude NaHCO3 homogenate and in
plasma membrane-enriched fraction. Protein concen-
trations were determined by the Bradford method
[29].
2.5. Analysis of PG
2.5.1. Extraction procedure
After labeling with the di¡erent precursors (see
Section 2), culture medium was collected, the cell
layer was washed twice with PBS and washings
were added to the medium. After addition of pro-
tease inhibitors at the required concentrations, the
sample was centrifugated (1000Ug, 15 min). Then,
the cell layer was treated twice with PBS containing
100 mg/ml heparin and protease inhibitors, for 30
min at 4‡C. Except for media used during enzymatic
digestion (see below), all bu¡ers needed in the sub-
sequent extractions, puri¢cations and analyses con-
tained the same mixture of protease inhibitors.
After elimination of peripheral PG by heparin, the
cell layer was either treated with trypsin (100 mg/ml
in PBS) for 3 min at 37‡C and the digestion was
stopped by soybean trypsin inhibitor (50 mg/ml), or
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with PI-PLC (0.2 IU/ml in Ham’s F-12-DMEM) for
1 h at 37‡C. Material spontaneously secreted (control
secretion) during enzymatic treatments was deter-
mined by incubating Sertoli cells for 3 or 60 min in
trypsin- and PI-PLC-free medium respectively. PG
radioactivity was determined in incubation medium
after enzymatic treatment and, at the same time, in
medium control, by solid phase assay (see Section
2.5.2.). The amount of enzymatically released PG
was calculated by subtracting the radioactivity of
control cell medium from the radioactivity of tryp-
sin- or PI-PLC-treated cell medium.
Cell layer, treated or not with hydrolytic enzymes,
was extracted with 0.5% (v/v) Triton X-100, 10 mM
Tris-HCl (pH 7.2) for 15 min at 37‡C, under gentle
shaking. The detergent extract was cleared by centri-
fugation (10 000Ug, 30 min).
Finally, cell layer not submitted to digestion by
trypsin or PI-PLC, but sequentially treated with hep-
arin and Triton X-100, was extracted with Tris-HCl
bu¡er (10 mM, pH 7.2) in the presence of 8 M urea
and 0.5% Triton X-100 (24 h at 4‡C). PG of this
extract were referred to extracellular matrix-associ-
ated PG.
2.5.2. Quantitative assay for HSPG and HS chains
PG and glycosaminoglycan (GAG) quanti¢cation
was performed by solid phase assay with slight mod-
i¢cations [30]. Samples were adjusted to 4 M urea,
0.5% Triton X-100, 50 mM Tris-HCl, 0.15 M NaCl,
pH 7.0 and spotted on four di¡erent cationic nylon
membranes, previously soaked in 50 mM Tris-HCl
bu¡er, pH 7.0 (TBS) containing 0.15 M NaCl, and
sandwiched in a dot blot apparatus. Under these
conditions, non-anionic and weakly anionic mole-
cules did not bind to the membrane. Two of the
four membranes were washed twice for 30 min on
a shaker platform, in TBS containing 0.9 M NaCl to
remove free GAG chains and their degradation prod-
ucts and bind only PG. In addition, one 0.15 M
NaCl-treated blot and one 0.9 M NaCl-treated blot
were submitted to nitrous acid treatment to speci¢-
cally assess HSPG- and HS-associated radioactivity
[31]. After rinsing with distilled water and ethanol,
blots were cut in segments bearing the imprint of an
individual dot and submitted to liquid scintillation
counting. PG radioactivity was directly determined
on 0.9 M NaCl-treated dot. GAG radioactivity was
calculated by subtracting radioactivity of 0.9 M
NaCl-treated dot from that of 0.15 M NaCl-treated
dot.
Results of quantitative analysis were the means of
four di¡erent experiments (Table 1).
2.5.3. Ion-exchange chromatography
Cell culture extracts were dialyzed against 10 mM
Tris-HCl (pH 7.2) bu¡er containing 4 M urea and
0.5% Triton X-100, and puri¢ed by passage over a
DEAE-Trisacryl column (5 ml) previously equilibrat-
ed with the same bu¡er. After sample application,
the column was rinsed with 10 ml of equilibration
bu¡er and then eluted with a gradient of NaCl
Table 1
Forms and distribution of [35S]heparan sulfate from Triton X-100 extract of cultured Sertoli cellsa
% of total 35S incorporated
into all HS forms
% of total
35S HSPG
% of total 35S hydrophobic
HSPG
HS-free chains and their degradation
products
68 þ 10.2 ^ ^
Non-hydrophobic HSPG (intracellular
presumed)
12 þ 2.2 37.5 þ 5.6 ^
Hydrophobic HSPG resistant to trypsin 4 þ 1.0 12.5 þ 3.4 20 þ 3.7
Hydrophobic HSPG accessible to trypsin
(integral membrane HSPG) and distributed
among
16 þ 1.9 50 þ 4.2 80 þ 8.9
PI-PLC susceptible HSPG 5 þ 0.6 16 þ 1.7 25.5 þ 2.7 (32%)b
PI-PLC resistant HSPG 11 þ 0.9 34 þ 4.1 54.5 þ 4.9 (68%)b
aHS-free chains and HSPG were quanti¢ed after anion-exchange chromatography, hydrophobic interaction chromatography and solid
phase assay on cationic nylon blot (see Section 2). These results are representative of four experiments (mean þ S.E.).
bValues in parentheses are calculated as percentage of total integral membrane HSPG (transmembrane HSPG+GPI-HSPG).
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(0^1.0 M in a total volume of 50 ml). A £ow rate of
25 ml/h was used and 1 ml fractions were collected.
Alternately, elution was performed stepwise, with 0.2
and 1.0 M NaCl, in urea bu¡er (each 20 ml).
PG fractions resulting from ion-exchange chroma-
tography were pooled and concentrated. After ad-
justing their NaCl concentration to 0.15 M by add-
ing 4 M urea bu¡er, they were loaded onto a 0.2 ml
DEAE-Trisacryl column. Bound PG were displaced
by a small volume (2 ml) of 4 M guanidine-HCl in
10 mM Tris-HCl, pH 7.2, 0.5% Triton X-100.
In some experiments, PG puri¢cation was per-
formed by FPLC on a Mono Q column, bound ma-
terial being eluted by a linear NaCl gradient (0^1.2
M) in Tris-HCl/urea bu¡er.
2.5.4. Gel chromatography
Plasma membrane extract was submitted to gel
chromatography on Sepharose CL-2B and Sepharose
CL-4B (1U55 cm) and elution was carried out with
4 M guanidine-HCl bu¡er, respectively in absence or
presence of Triton X-100. Size exclusion of radiola-
beled PG was performed on Sepharose CL-4B (1U55
cm) with 4 M urea bu¡er as eluent. Flow rate of each
gel ¢ltration was 6 ml/h and 0.4 ml fractions were
collected.
2.5.5. Hydrophobic interaction chromatography and
liposome intercalation
Triton X-100 present in the di¡erent puri¢ed PG
extracts was exchanged for dialyzable octyl glucoside
detergent. PG samples were dialyzed against 10 mM
Tris-HCl bu¡er, 4 M urea, pH 7.2 and loaded onto a
0.5 ml DEAE-Trisacryl column equilibrated with the
same bu¡er. The column was washed sequentially
with 20 ml of Tris-HCl urea bu¡er and with 10 ml
of Tris-HCl urea bu¡er containing 50 mM octyl glu-
coside. Bound proteoglycans were displaced with
10 mM Tris-HCl bu¡er, pH 7.2, 4 M guanidine chlo-
ride, 75 mM octyl glucoside. Samples were dialyzed
against 10 mM Tris-HCl bu¡er, pH 7.2, 4 M guani-
dine chloride, then mixed with 1.5 ml of octyl-Se-
pharose CL-4B and put overnight on a shaker, at
4‡C. Octyl-Sepharose CL-4B gel was transferred to
a small column and the gel was successively eluted
with 15 ml of 10 mM Tris-HCl bu¡er, pH 7.2, 4 M
guanidine chloride, and 15 ml of the same bu¡er
containing 1% Triton X-100. Fractions of 1 ml
were collected.
To test PG insertion into liposomes, Triton X-100
present in the samples was exchanged for octyl glu-
coside by the method described above. Incorporation
of DEAE-Trisacryl puri¢ed lipophilic PG into lipo-
somes was performed in the presence of phosphati-
dylcholine. L-K-Phosphatidylcholine from egg yolk,
solubilized in chloroform/methanol (9:1) was evapo-
rated to dryness under a stream of nitrogen. Sample,
dissolved in 10 mM Tris-HCl bu¡er, pH 7.2, 4 M
guanidine chloride containing 75 mM octyl gluco-
side, was added to phosphatidylcholine (5 mg of
phospholipid/ml of sample solution). The mixture
was dialyzed overnight against 10 mM Tris-HCl
bu¡er, pH 7.2, 4 M guanidine chloride without octyl
glucoside, at room temperature, to induce intercala-
tion of hydrophobic material into liposomes. PG in-
sertion into phosphatidylcholine micelles was re-
vealed by gel ¢ltration on Sepharose CL-4B (1U55
cm), with detergent-free 10 mM Tris-HCl bu¡er, pH
7.2, 4 M guanidine chloride as eluent.
2.5.6. Enzymatic digestion and nitrous acid
degradation
Puri¢ed HSPG were dissolved in a bu¡er pH
7.0 containing 50 mM Tris-HCl, 100 mM NaCl,
100 mg/ml bovine serum albumin, 50 mM 6-amino-
hexanoic acid, 2.5 mg/ml pepstatin, 1 mM phenyl-
methylsulfonyl £uoride, 20 mg/ml leupeptin. After
addition of heparitinase (60 mIU/ml), the mixture
was incubated for 3 h at 37‡C. Alternately, heparan
side chains were degraded by deaminative cleavage
using the pH 1.5/HNO2 method [31].
2.6. Core protein electrophoresis
Puri¢ed hydrophobic HSPG (extracted by Triton
X-100 and successively submitted to ion-exchange
chromatography and hydrophobic interaction chro-
matography) were treated by PI-PLC (0.6 U/ml) for
2 h at 37‡C. After dialysis, the resulting material was
mixed with phosphatidylcholine and size fractiona-
tion was performed on Sepharose CL-4B (see Section
2.5.5.). Proteoglycans intercalated and non-interca-
lated into lipidic vesicles corresponded respectively
to transmembrane HSPG and GPI-HSPG which
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have lost their hydrophobic properties after PI-PLC
treatment.
The two HSPG families were dissolved in 100 mM
Tris-HCl bu¡er, pH 7.2, containing 10 mM octyl
glucoside and separately bound to DEAE-Trisacryl
(1 ml) equilibrated in the same bu¡er. After 30 min
at 4‡C, the suspension was centrifugated (3000Ug,
5 min), the supernatant discarded and the anion-ex-
change matrix was washed with Tris-HCl bu¡er.
Membrane HSPG bound to DEAE-Trisacryl were
iodinated with [125I]Na (1 mCi) and chloramine T
(1 mg/ml), for 5 min at room temperature, and the
reaction was stopped by adding K2S2O5 (5 mM) and
KI (10 mM). DEAE-Trisacryl matrix was abun-
dantly rinsed with 100 mM Tris-HCl (pH 7.2) bu¡er
containing 4 M urea and 0.5% Triton X-100 to elim-
inate free [125I]Na. [125I]HSPG were eluted with the
same bu¡er containing 1 M NaCl, puri¢ed by FPLC-
Mono Q chromatography, dialyzed against distilled
water and lyophilized. After heparitinase digestion,
125I-labeled core proteins were submitted to electro-
phoresis.
Linear gradient gel (4^15% polyacrylamide) was
used in a denaturing sodium dodecyl sulfate-polyac-
rylamide gel electrophoresis (SDS-PAGE) system,
with the bu¡er system of Laemmli. Before electro-
phoresis, samples were adjusted at 2% (w/v) in elec-
trophoresis bu¡er and boiled for 5 min. Samples
running under reducing conditions were supple-
mented with 2% L-mercaptoethanol. After electro-
phoresis (6 h, 30 mA/gel), gel was ¢xed in 50% meth-
anol-3% acetic acid, rinsed in distilled water, dried
under vacuum, and subjected to autoradiography in
the presence of Kodak XAR-5 ¢lm.
Results of qualitative analysis were representative
of three di¡erent experiments.
3. Results
3.1. Cell surface-associated HSPG
In the preparation of Sertoli cell plasma mem-
branes, obtained on sucrose discontinuous gradient,
5P-nucleotidase was increased 13.4-fold in speci¢c ac-
tivity relative to the initial homogenate (6404 þ 843
IU/mg protein vs. 476.8 þ 63.7 IU/mg protein, n = 3)
and acid phosphatase was increased 3.4-fold
(0.078 þ 0.009 IU/mg protein vs. 0.023 þ 0.005
IU/mg protein, n = 3). These results indicated that
fraction recovered at the interface of sucrose solu-
tions (10^32%) was mostly enriched in plasma mem-
branes and partially contaminated by lysosomes.
The plasma membrane preparation was solubilized
in 4 M guanidine chloride-Tris HCl bu¡er, at 4‡C for
24 h and chromatographed on Sepharose CL-2B
(Fig. 1A). 35S-Radiolabeled material distributed as
a peak in the void volume (peak I) and a peak at
Kav = 0.90 (peak II). Fractions of peak I were pooled
(bar indicated), concentrated, adjusted to 5% Triton
X-100 ¢nal concentration, chromatographed on Se-
pharose CL-4B with guanidine chloride bu¡er con-
taining 5% Triton X-100 as eluent (Fig. 1B). Under
these conditions, about 90% of the 35S-labeled mate-
rial originally emerging in the void volume of the
Fig. 1. Cell surface-associated HSPG. (A) Puri¢ed plasma mem-
brane of [35S]sulfate-labeled Sertoli cells was extracted with free
detergent Tris-HCl bu¡ered 4 M guanidine chloride and the ex-
tract was chromatographed on Sepharose CL-2B in the same
bu¡er. (B) Peak I of panel A (bar indicated) was supplemented
with Triton X-100 (5% ¢nal concentration) and chromato-
graphed on Sepharose CL-4B in Tris-HCl bu¡ered 4 M guani-
dine chloride containing 5% Triton X-100, before (E) and after
(b) nitrous acid degradation. Hydrophobic features of HSPG
from peak I were assessed, as described in Section 2, by (C) hy-
drophobic interaction chromatography on octyl-Sepharose CL-
4B (hydrophobic HSPG were eluted by bu¡er containing 1%
Triton X-100) and (D) by intercalation into phosphatidylcholine
liposomes and gel ¢ltration on Sepharose CL-4B.
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Sepharose CL-2B, eluted as single peak at Kav = 0.33.
This material was totally susceptible to nitrous acid
degradation (Fig. 1B). These results showed that
peak I contained exclusively HSPG copurifying
with plasma membrane. When extracted from plas-
ma membrane by detergent-free chaotropic solvent,
HSPG interacted with membrane lipids to form ag-
gregates which were disrupted by Triton X-100. Peak
II on Sepharose CL-2B (Kav = 0.90) may represent
PG degradation products, associated to contaminat-
ing lysosomal fraction, and previously detected in
Sertoli cell Triton X-100 extract [19].
The lipophilic features of peak I HSPG were as-
sessed by hydrophobic interaction chromatography
and intercalation into liposomes. HSPG were essen-
tially retained on octyl-Sepharose CL-4B (Fig. 1C)
and eluted with 1% Triton X-100. Furthermore,
HSPG were incorporated into phosphatidylcholine
micelles since they were detected in the void volume
of the Sepharose CL-4B column instead of emerging
at Kav = 0.33 (Fig. 1D).
3.2. Cell layer trypsin-susceptible HSPG
Trypsin can release integral membrane PG. After
removing the 35S-metabolically labeled Sertoli cell
culture medium, the cell layer was successively
washed with PBS and heparin solution, treated or
not by trypsin (100 mg/ml) and extracted by 0.5%
Triton X-100. The detergent extracts from control
and trypsin-treated cell layer were anion-exchange
puri¢ed and chromatographed on Sepharose CL-4B
(Fig. 2A).
Mild digestion with trypsin decreased by approx.
80% the total cell layer-associated HSPG (Table 1),
resulting in a major reduction of the peak emerging
at Kav 0.33, whereas the peaks with Kav 0.50 and 0.80
remained practically unchanged, representing intra-
cellular GAG chains and their degradation products
respectively [19].
Puri¢ed detergent extracts were further submitted
to chromatography on octyl-Sepharose CL-4B (Fig.
2B). Comparison of elution pro¢les indicated that
trypsin dramatically decreased the hydrophobic
HSPG fraction displaced from gel by 1% Triton X-
100 but did not modify the unbound peak which
represented intracellular species.
Following trypsin treatment, the lipophilic HSPG
fraction was reduced from 62.5% to 12.5% of the
total detergent extract HSPG. The proportion of
the total cellular PG released from the cell surface
by trypsin accounted for this reduction in cellular
lipophilic HSPG. Thus, about 80% of the hydropho-
bic HSPG are integrated in the plasma membrane,
while the remainder (20%) was not accessible to tryp-
sin and presumably located in the intracellular com-
partment (Table 1).
The trypsin-susceptible 35S-labeled integral mem-
brane PG released in the incubation medium were
DEAE-Trisacryl puri¢ed, analyzed by gel chroma-
tography on Sepharose CL-4B and compared with
those of control culture medium (Fig. 2C). These
released HSPG (as revealed following nitrous acid
degradation, data not shown) eluted with a
Kav = 0.38 whereas the integral membrane HSPG
Fig. 2. Trypsin susceptibility of cultured Sertoli cell HSPG.
[35S]Sulfate-labeled cell layer Sertoli cells were washed with hep-
arin solution, treated or not (control) with trypsin (100 Wg/ml,
3 min, 37‡C), then extracted with 0.5% Triton X-100. Extract
was puri¢ed by DEAE-Trisacryl chromatography and analyzed.
Detergent extract from cells submitted (E) or not (b) to mild
trypsin digestion was chromatographed (A) on Sepharose CL-
4B with 4 M urea bu¡er as eluent and (B) on octyl-Sepharose
CL-4B. Hydrophobic HSPG were eluted by bu¡er containing
1% Triton X-100. (C) Trypsin-susceptible 35S-labeled integral
membrane HSPG released in the incubation medium were
DEAE-Trisacryl puri¢ed and chromatographed on Sepharose
CL-4B (b). Control medium sample (E) was analyzed with the
same procedure.
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chromatographed with a Kav = 0.33 (Fig. 1B). After
protease treatment, the decrease in HSPG species
apparent molecular mass may almost result from re-
moval of membrane insertion and cytoplasmic do-
mains of transmembrane HSPG [32] and from pos-
sible proteolytic cleavage a¡ecting some GPI-HSPG,
near the C-terminal end of the core protein [33].
3.3. Cell layer PI-PLC-susceptible HSPG
PI-PLC provides a useful experimental tool to
demonstrate the presence of GPI molecules and their
surface localization [34]. Cells were labeled with
[35S]sulfate for 48 h and then incubated in fresh me-
dium with or without PI-PLC (0.2 IU/ml) for up to
120 min, allowing a direct quanti¢cation of the GPI-
anchored cell surface proteoglycans. [35S]PG released
in the medium were measured at 0, 10, 30, 50, 60, 90
and 120 min (Fig. 3). At each time point, [35S]PG
radioactivity in the medium was 2^3-fold higher in
PI-PLC-treated cells than in control cells. Under our
experimental conditions, the totality of the radioac-
tivity associated to GPI-PG was released after 1 h
PI-PLC treatment (Fig. 3).
In other experiments, Sertoli cells were double ra-
diolabeled with [35S]sulfate and [3H]inositol for 48 h.
Medium was removed, the cell layer was washed with
PBS containing heparin (100 mg/ml), then treated or
not with PI-PLC (0.2 IU/ml) for 1 h. PG released by
the enzymatic treatment were puri¢ed by DEAE-
Trisacryl chromatography. Radiolabeled molecules
secreted in the absence of the enzyme during the
same incubation period (control secretion) were sim-
ilarly chromatographed.
PI-PLC released 16% of the total HSPG present in
Sertoli cells (Table 1). After ion-exchange chroma-
tography, material spontaneously secreted was re-
solved as a unique [35S]sulfate- and [3H]inositol-la-
beled peak, eluted by 0.4 M NaCl (Fig. 4A).
Treatment by PI-PLC resulted in an increase in
[3H]inositol and [35S]sulfate radioactivities in this
peak (Fig. 4C). The total [3H]inositol radioactivity/
total [35S]sulfate radioactivity ratio of the peak from
control culture medium and from PI-PLC-treated
culture medium was respectively 0.86 and 1.42.
This con¢rms that PI-PLC selectively released GPI-
PG.
Fig. 3. PI-PLC susceptibility of cultured Sertoli cell HSPG.
Time course of GPI-PG release. Sertoli cells were labeled with
[35S]sulfate. After removing the labeling medium, cells were in-
cubated in fresh medium without (b, control) or with 0.2
IU/ml PI-PLC (a) for up to 120 min. Aliquots of media were
collected at each time point and the amount of [35S]HSPG was
measured by quantitative solid phase assay (see Section 2)
(n = 3). The amount of enzymatically released GPI-PG was cal-
culated by subtracting the radioactivity of control cell medium
from the radioactivity of PI-PLC-treated cell medium (O).
Fig. 4. Analysis of HSPG released in incubation medium after
PI-PLC treatment. Sertoli cells were double labeled with
[35S]sulfate (a) and [3H]inositol (F) for 48 h; the labeling me-
dium was removed, cells were incubated in fresh medium with-
out (A,B, control) or with 0.2 IU/ml PI-PLC (C,D) for 60 min.
Medium HSPG were puri¢ed by an anion-exchange DEAE-
Trisacryl column (A,C). The [35S]sulfate and [3H]inositol double
labeled peak emerging on the DEAE-Trisacryl column (frac-
tions 21^38) was recovered and submitted to gel ¢ltration on
Sepharose CL-4B (B,D).
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Double labeled PG puri¢ed on DEAE-Trisacryl
were then analyzed by Sepharose CL-4B gel ¢ltra-
tion. For control cells (Fig. 4B), [35S]PG eluted as
two main peaks, one at Kav = 0.05 and the other at
Kav = 0.60 with a discrete shoulder at Kav = 0.40 co-
inciding with a [3H]inositol radioactivity peak. PI-
PLC speci¢cally released a peak eluted at Kav = 0.40
of [35S]PG which was also [3H]inositol labeled (Fig.
4D). Peak fractions were pooled, treated with nitrous
acid and re-chromatographed on Sepharose CL-4B
leading to the emergence of the labeling in the total
volume (not shown). These results indicated that the
peak eluted at Kav = 0.40 contained HSPG with a
[3H]glycosylphosphatidylinositol anchor. In both
control and PI-PLC-treated material, the peak at
Kav = 0.60 was [3H]inositol radiolabeled and suscep-
tible to nitrous acid treatment (data not shown). Due
to their apparent molecular mass, the molecular spe-
cies of this peak may represent degradation products
of GPI-PG. The pool containing large PG (Kav =
0.05) was devoid of [3H]inositol labeling and was
not further analyzed.
The PI-PLC-treated cell layer was extracted with
Triton X-100 and after DEAE-Trisacryl puri¢cation,
the extract was submitted to hydrophobic interaction
chromatography (Fig. 5A). Compared to control ex-
tract, the HSPG fraction bound to the gel was re-
duced by 30^35%.
Puri¢ed HSPG released in the medium by PI-PLC
treatment did not bind to octyl-Sepharose (Fig. 5B).
This result suggested that the hydrophobic properties
of GPI-PG were exclusively due to the presence of
the phospholipid anchor.
Coupled results obtained after trypsin and PI-PLC
Fig. 6. Core protein electrophoresis of integral membrane
HSPG. Sertoli cells were labeled with [35S]sulfate. Integral mem-
brane HSPG were extracted with Triton X-100, puri¢ed by
anion exchange and hydrophobic interaction chromatographies,
then PI-PLC treated. GPI-HSPG and transmembrane HSPG
populations were separated after liposome intercalation and Se-
pharose CL-4B gel ¢ltration. Core proteins were 125I-radiola-
beled (see Section 2) and HS chains submitted or not to degra-
dation by heparitinase or nitrous acid. Samples were resolved
by gradient SDS-PAGE in the presence or absence of L-mer-
captoethanol and visualized by autoradiography. (A) Trans-
membrane HSPG; (B) GPI-HSPG.
Fig. 5. Hydrophobicity test for HSPG after PI-PLC treatment.
[35S]Sulfate-labeled Sertoli cells were washed with heparin solu-
tion, treated (b) or not (E, control) with 0.2 IU/ml PI-PLC for
1 h. Incubation medium was recovered and cell layer extracted
with 0.5% Triton X-100. Medium and detergent extract were
puri¢ed by anion exchange on a DEAE-Trisacryl column and
chromatographed on octyl-Sepharose CL-4B. Hydrophobic
HSPG were eluted with 1% Triton X-100. (A) Triton X-100 ex-
tract ; (B) PI-PLC incubation medium.
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digestion indicated that, in Sertoli cells, transmem-
brane HSPG and GPI-HSPG represented respec-
tively 68% and 32% of the integral membrane
HSPG (Table 1).
3.4. Isolation of hydrophobic HSPG core proteins
GPI-HSPG and transmembrane HSPG were dis-
tinguished and separated on the basis of their PI-
PLC susceptibility. Their respective core proteins
were 125I-radiolabeled, isolated and puri¢ed as de-
scribed in Section 2. 125I-Labeled core proteins
were analyzed by SDS-polyacrylamide gel electro-
phoresis and revealed by autoradiography.
Under reducing or non-reducing conditions and
prior to heparitinase treatment, PI-PLC-resistant
[125I]HSPG (syndecan species presumed) migrated
as a di¡use band in the high molecular mass region
(Fig. 6A, lanes 1 and 4). Heparitinase digestion re-
sulted in an important decrease of this band (residual
radioactivity beyond 200 kDa probably represented a
small amount of undigested PG) and emergence of
125I-labeled bands at 60^68 kDa (Fig. 6A, lanes 2
and 3).
Under reducing conditions and prior to deglycana-
tion, PI-PLC-susceptible [125I]HSPG (glypican spe-
cies presumed) remained as a smear on the top of
the gel (Fig. 6B, lane 1). After heparitinase digestion
or nitrous acid treatment, a band with an apparent
molecular mass of 64^65 kDa appeared (Fig. 6B,
lanes 2 and 3).
4. Discussion
In the present work, HS molecules isolated from
cultured immature Sertoli cells were discriminated on
the basis of their high anionic charge, hydrodynamic
size, lipophilic properties and susceptibility to trypsin
and PI-PLC. We have shown that in detergent ex-
tract, about 65% of 35S labeling was associated to
HS-free chains and their degradation products (Ta-
ble 1) [19]. Probably, these compounds resulted from
the HSPG catabolism pathway and were located in
the lysosomal compartment. This localization was
suggested by the fact that isolated plasma membrane,
partially contaminated by lysosomal components,
contained low molecular size [35S]sulfate species
emerging in the total volume of Sepharose CL-2B
(Fig. 1, peak II). [35S]Sulfate is also incorporated in
the sulfated glycoprotein-2 (SGP-2)/clusterin (51.4
kDa) that is speci¢cally produced in the testis, by
Sertoli cells [35]. It was shown that another epithelial
cell type (non-ciliated cells of e¡erent ducts) synthe-
sizes an endogenous form of SGP-2 that is targeted
to the lysosomal compartment [36]. This process,
although not described in Sertoli cells, might be pos-
sible. However, nitrous acid practically degraded all
peak II, revealing the exclusive presence of
[35S]heparan sulfate.
The remaining (35%) was incorporated into HSPG
including a non-hydrophobic population (37.5% of
total HSPG, Table 1). Non-hydrophobic HSPG
may correspond to HSPG in the synthesis process,
constitutively devoid of lipophilic domain and des-
tined to secretion [37]. On the other hand, it may
represent degraded forms of integral membrane
HSPG, especially syndecans, since it was shown
that these transmembrane HSPG were both released
in medium and endocytosed. After internalization,
they were submitted to a slow and stepwise degrada-
tion process which generated distinct degradation in-
termediates [38]. Some of the non-hydrophobic inter-
mediates may derive from partially catabolized
syndecans without a membrane insertion domain.
Trypsin releases integral membrane HSPG and
separates the core proteins from their hydrophobic
anchor which remains plasma membrane associated.
Despite trypsin digestion, a minor fraction of deter-
gent extract HSPG were trypsin resistant and re-
tained hydrophobic properties (12.5% of total
HSPG and 20% of total hydrophobic HSPG). Tryp-
sin inaccessibility suggested that this HSPG popula-
tion was not present on the cell surface but located
inside the cell. It may consist of neo-synthesized in-
tegral membrane HSPG in advance from the Golgi
apparatus to the plasma membrane [37].
Hydrophobic trypsin-susceptible HSPG were pre-
sumed to be plasma membrane constituents. This
localization was further con¢rmed by analysis of pu-
ri¢ed Sertoli cell plasma membrane. (i) When deter-
gent-free 4 M guanidine chloride extract from puri-
¢ed plasma membrane was submitted to gel ¢ltration
on Sepharose CL-2B, one peak emerged in the void
volume of the column and consisted of HSPG aggre-
gates associated to membrane lipids by hydrophobic
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interactions; these HSPG-lipid complexes were dis-
sociated after detergent addition and eluted at
Kav = 0.33 on Sepharose CL-4B. (ii) Additional evi-
dence of hydrophobicity of HSPG from plasma
membrane extract was provided by chromatography
on hydrophobic matrix (octyl-Sepharose CL-4B) and
liposome insertion.
Alternatively, the Sertoli cell layer was trypsin
treated, then extracted by Triton X-100 and extract
was puri¢ed and subjected to gel ¢ltration on Se-
pharose CL-4B. Under these conditions, the HSPG
peak eluted at Kav = 0.33 was decreased by about
80%. In the same way, the hydrophobic HSPG pop-
ulation retained on octyl-Sepharose CL-4B was re-
duced to about 20% of the control value. These re-
sults were in good agreement with those obtained
from the experimental quantitative procedure de-
scribed in Table 1. Moreover, the extracellular do-
main of the HSPG population released from the cell
surface by trypsin was apparently smaller than the
parent integral membrane HSPG population
(Kav = 0.38 vs. 0.33 for parent molecules, on Sephar-
ose CL-4B) and was devoid of lipophilic features.
It is known that trypsin cleaves, in vitro, syndecan
core proteins at a site adjacent to the membrane in-
sertion domain, which was represented by a dibasic
sequence in the syndecan-1, -2 and -3 and a basic
residue in the syndecan-4 [39]. The syndecan ectodo-
main was released in the trypsin incubation medium
whereas transmembrane and cytoplasmic domains
were always embedded in the plasma membrane.
Furthermore, the primary structure of six known
glypicans included basic sequences susceptible to
trypsin, some of them located between the ¢xation
sites of HS chains and the plasma membrane [10,11].
A more speci¢c study of glypican was achieved by
the use of PI-PLC which releases the whole HSPG
with the terminal phosphate group of inositol still
attached, whereas diacylglycerol remains associated
to the external lea£et of the membrane. Addition
of the lipase to the Sertoli cell layer induced, in the
incubation medium, a rapid and time-dependent ac-
cumulation of HSPG having lost their hydrophobic
properties. Furthermore, PI-PLC susceptible HSPG
incorporated inositol which is a characteristic residue
of the GPI anchor. These results indicated the pres-
ence of glypican on the Sertoli cell surface which
represented about one third of integral membrane
HSPG (Table 1).
The hydrophobic features of detergent-solubilized
cellular HSPG, their isolation from puri¢ed plasma
membranes, their release by phospholipase C and,
more extensively, by mild trypsin treatment, strongly
suggested an integral membrane disposition and the
possible presence of glypican and syndecan species.
Furthermore, PG from the medium, cell periphery
and extracellular matrix revealed no hydrophobic
properties since they were unable to insert into lipo-
somes (data not shown).
Electrophoresis of hydrophobic HSPG core pro-
teins, susceptible or resistant to PI-PLC, revealed
the existence of two integral membrane HSPG fam-
ilies in immature Sertoli cells. A band of 64^65 kDa
corresponding to GPI-HSPG was observed that
might represent glypican-1: (i) by the RT-PCR tech-
nique, we have shown that immature Sertoli cells
expressed at least glypican-1 mRNA [40]; (ii) its ex-
pression, although observed in cells of endothelial
and mesenchymal origin, is prevalent in polarized
epithelial cells [41]; and (iii) glypican-2 to -6 were
absent or weakly expressed in mammalian testis
[11,42,43]. However, the con¢rmation of glypican
identity remains to be established by the use of spe-
ci¢c monoclonal antibody.
Glycosidase-digested syndecans members, submit-
ted to electrophoresis in SDS-polyacrylamide gel, mi-
grated as bands corresponding to 2 and 4 times the
predicted molecular mass of monomeric protein. In-
deed, all syndecans seem to be able to form SDS-
resistant oligomers, especially dimers [5]. In accor-
dance with these observations, our results have
shown that core proteins of PI-PLC-resistant hydro-
phobic HSPG localized in electrophoretogram re-
gions where size markers are detected with a higher
molecular mass than any known syndecan [39].
Moreover, the reduction of samples by the addition
of L-mercaptoethanol did not modify the electropho-
retic pro¢le. Recent studies have con¢rmed that syn-
decan core proteins can self-associate and that multi-
merization requires di¡erent core protein domains
depending on the syndecan isoforms, as described
for syndecan-2 [44,45] and syndecan-3 [46]. In vivo,
self-association of syndecan core proteins was specu-
lated to correlate with the recruitment of cytoskele-
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ton proteins and initiation of signaling pathway ac-
tivation [5,14]. Since syndecan-1 and syndecan-4
mRNAs were present in immature Sertoli cells [40],
these bands may correspond at least to syndecan-1
and-4 core proteins. However, the existence of other
glypican or syndecan isoforms, not examined, cannot
be ruled out. These results should be considered by
further monoclonal antibody approach.
The implication of integral membrane HSPG in
biological functions of Sertoli cells is still elusive.
Sertoli cells are the target of numerous endocrine
and paracrine factors originating from pituitary
gland (FSH) and testis cells such as peritubular cells,
Leydig cells and germ cells [47]. As coreceptors, syn-
decans and glypicans sequester soluble ligands, mod-
ulate their activity and control the assembly of the
resulting signaling complex. Previous work has
shown that undersulfation of Sertoli cell surface
HSPG induced enhancement of FSH-stimulated es-
tradiol synthesis [25] but did not modify the interac-
tion between the FSH receptor and its ligand (data
not shown). This latter observation contrasts
strongly with the e¡ects resulting from the decrease
in HS sulfate charge on the complex formation of
growth factors, chemokines and cytokines with their
respective receptors [5,48,49]. However, indirect evi-
dence suggested that increased estradiol production
is due, for one part, to the persistence of a high
cAMP level following the decrease in cAMP phos-
phodiesterase activity. It was postulated that altera-
tion of catalytic capacities might be the consequence
of the enzyme translocation from cytosol to plasma
membrane [25]. If directly con¢rmed, transmembrane
HSPG involvement in subcellular localization of
cAMP phosphodiesterase might be considered a rem-
iniscence of protein kinase C recruitment and activity
regulation by the cytoplasmic variable domain of
syndecan-4 [44].
In testis, Sertoli cells play highly diversi¢ed roles
by participating in the maintenance of seminiferous
tubule integrity through interactions with peritubular
cells and providing structural support for spermato-
genesis. Many of these events, mediated by soluble
and insoluble ligands, probably require HSPG col-
laboration. Whether each of the integral membrane
HSPG forms is devolved to speci¢c function(s) re-
mains to be cleared up.
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